Support

Support Options

Submit a Support Ticket

 

Tags: medicine

Resources (1-20 of 27)

  1. [Illinois] Microfluidics and Nanotechnology for Biology and Medicine

    08 Aug 2014 | Online Presentations | Contributor(s): Rashid Bashir

    Rashid Bashir completed his BSEE from Texas Tech University as the highest ranking graduate in the College of Engineering in Dec 1987. He completed his MSEE from Purdue University in 1989 and...

    http://nanohub.org/resources/21391

  2. [Illinois] How to Break the "Fundamental" Limits of Nanobiosensing

    07 Apr 2014 | Online Presentations | Contributor(s): Muhammad A. Alam

    As the future of Moore’s law of transistor scaling appears uncertain, electronics is being reinvented by broadening the focus to other areas including macroelectronics (electronics of large,...

    http://nanohub.org/resources/20795

  3. [Illinois] Evolving Complex Systems in Biology and Medicine

    04 Feb 2014 | Online Presentations | Contributor(s): Dr. Hava Siegelmann

    Feb. 21, 2013. BioEngineering Seminar Series. University of Illinois Urbana-Champaign "Evolving Complex Systems in Biology and Medicine" Dr. Hava Siegelmann, Director of BINDS lab and professor,...

    http://nanohub.org/resources/20241

  4. [Illinois] The Role of Nanoparticle Surface Chemistry in Alveolar Macrophage Inflammatory Response

    12 Aug 2013 | Online Presentations | Contributor(s): Valerie Leppert

    Dr. Leppert is an associate professor in the School of Engineering at the University of California - Merced. Dr. Leppert received her Ph.D. in Materials Science and Engineering from Northwestern...

    http://nanohub.org/resources/19092

  5. [Illinois] CNST 2012: Nanostructured Silicon Optical Materials as Multifunctional Cell Culture Substrates

    02 Jun 2013 | Online Presentations | Contributor(s): Kris Killian

    http://nanohub.org/resources/14041

  6. [Illinois] CNST 2012: Nanotechnology-mediated Sensing of Angiogenesis

    02 Jun 2013 | Online Presentations | Contributor(s): Princess I. Imoukhuede

    http://nanohub.org/resources/14042

  7. [Illinois] CNST 2012: Gold Nanoparticles In, On, and Around Cells

    02 Jun 2013 | Online Presentations | Contributor(s): Cathy Murphy

    http://nanohub.org/resources/14043

  8. [Illinois] CNST 2012: Translational Research on Micro and Nanobionics Devices for Mobile and Social Sensing Applications

    02 Jun 2013 | Online Presentations | Contributor(s): Gang Logan Liu

    http://nanohub.org/resources/14044

  9. [Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo

    02 Aug 2012 | Online Presentations | Contributor(s): Susan E. Clare

    http://nanohub.org/resources/14921

  10. [Illinois] Cancer Community Symposium 2012: T Cell Receptors For Potential Cancer Immunotherapy Applications: Single Chain T Cell Receptors Circumvent Mispairing with Endogenous TCR and Mediate T Cell Activity

    09 May 2012 | Online Presentations | Contributor(s): David H. Aggen

    To improve the immune response to cancer, gene therapy with tumor-specific T cell-receptors (TCRs) provides an attractive approach to effectively arm patients T cells for tumor cell destruction. A...

    http://nanohub.org/resources/13951

  11. [Illinois] Cancer Community Symposium 2012: Imaging Estrogen Receptors and Estrogen-Receptor Function in Breast Cancer by Positron Emission Tomography (PET): Improved Selection of Patients for Benefit from Endocrine Therapies

    09 May 2012 | Online Presentations | Contributor(s): John A. Katzenellenbogen

    The growth of many breast cancers is regulated by estrogens, and these cancers can be treated effectively with endocrine therapies (ET). Identifying patients who will benefit from ET, however,...

    http://nanohub.org/resources/13950

  12. [Illinois] Cancer Community Symposium 2012: The Man with the Crateriform Lesion: Advanced Squamous Cell Carcinoma

    09 May 2012 | Online Presentations | Contributor(s): Joseph Brancheck

    Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer in the United States and accounts for 20 percent of non-melanoma skin cancers; in addition, it is the second...

    http://nanohub.org/resources/13949

  13. [Illinois] Cancer Community Symposium 2012: Speaking Up: The Patient Push for Accelerating Progress in Cancer Research

    09 May 2012 | Online Presentations | Contributor(s): Leslie Hammersmith

    Medical research empowers us to fight cancer, and advocacy empowers us to ensure that it addresses the needs of people affected by cancer. Advocacy helps us get through our cancer experiences,...

    http://nanohub.org/resources/13948

  14. [Illinois] Cancer Community Symposium 2012: Materials Science vs. Metastasis

    09 May 2012 | Online Presentations | Contributor(s): Daniel A. Heller

    Metastasis, the spread of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the greatest challenges in cancer treatment today. For many patients, by the time...

    http://nanohub.org/resources/13947

  15. [Illinois] Cancer Community Symposium 2012: Chemical Imaging for Histopathology: An Emerging Route for Molecular and Structural Analysis of Tissues

    09 May 2012 | Online Presentations | Contributor(s): Michael Walsh

    Mid-Infrared (IR) spectroscopic imaging is an emerging approach to derive chemical images from tissues based on their inherent biochemistry. Histologic diagnosis is the gold standard for...

    http://nanohub.org/resources/13946

  16. [Illinois] Cancer Community Symposium 2012: Panel Discussion

    09 May 2012 | Online Presentations

    Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith...

    http://nanohub.org/resources/13945

  17. [Illinois] Cancer Community Symposium 2012: Understanding and Targeting Transcription in Hematological Malignancies

    09 May 2012 | Online Presentations | Contributor(s): Jonathan D. Licht

    Abnormalities in the epigenetic regulation of chromatin structure and function can lead to aberrant gene expression and cancer development. Epigenetic regulators can be affected by chromosomal...

    http://nanohub.org/resources/13944

  18. [Illinois] Cancer Community Symposium 2012: The Inhibitory Effects of the Antifibrotic Drug Halofuginone on Uterine Leiomyoma Smooth Muscle Cells

    09 May 2012 | Online Presentations | Contributor(s): Faezeh Koohestani

    Uterine leiomyomas are the most prevalent benign tumors of the reproductive tract in women. Available treatments for leiomyomas are limited to surgical procedures or hormonal therapy, which are...

    http://nanohub.org/resources/13943

  19. [Illinois] Cancer Community Symposium 2012: Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling

    09 May 2012 | Online Presentations | Contributor(s): Elvira de Mejia

    Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling Lunasin is a...

    http://nanohub.org/resources/13942

  20. [Illinois] Cancer Community Symposium 2012: A Sensitivity Scale for Targeting T Cells with Chimeric Antigen Receptors (CAR) and Bispecific T Cell Engagers (BiTE)

    09 May 2012 | Online Presentations | Contributor(s): Jennifer Stone

    Using a patients immune system to target cancer and maintain long-term surveillance is an attractive goal. Although T cells can respond potently to tumors, immune tolerance mechanisms often result...

    http://nanohub.org/resources/13941

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.